Bank Of Montreal Ginkgo Bioworks Holdings, Inc. Transaction History

Bank Of Montreal

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$1.26 - $1.79 $39,237 - $55,742	-31,141 Reduced 71.63%	12,331 $20,000
Q3 2023 Nov 01, 2023	BUY	$1.61 - $2.54 $7,230 - $11,407	4,491 Added 11.52%	43,472 $78,000
Q2 2023 Aug 02, 2023	SELL	$1.14 - $1.95 $2,259 - $3,864	-1,982 Reduced 4.84%	38,981 $72,000
Q1 2023 Jun 13, 2024	BUY	$1.2 - $2.19 $16,716 - $30,506	13,930 New	13,930 $18,000
Q4 2022 Feb 01, 2023	SELL	$1.63 - $3.52 $2,337 - $5,047	-1,434 Reduced 3.38%	40,963 $69,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $11,293 - $57,861	15,471 Added 57.46%	42,397 $134,000
Q2 2022 Aug 11, 2022	BUY	$2.2 - $4.2 $33,167 - $63,319	15,076 Added 127.22%	26,926 $73,000
Q1 2022 May 12, 2022	SELL	$2.83 - $8.69 $33,818 - $103,845	-11,950 Reduced 50.21%	11,850 $50,000
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $197,778 - $355,096	23,800 New	23,800 $214,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.